Table of Contents
ISRN Pharmacology
Volume 2012 (2012), Article ID 170935, 4 pages
http://dx.doi.org/10.5402/2012/170935
Research Article

How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD

1Department of Paediatrics, Caritas Hospital, 97980 Bad Mergentheim, Germany
2Department of Paediatrics, The University of Western Ontario, London, ON, Canada N6A 5W9
3Department of Pediatric Cardiology, Hannover Medical School, 30625 Hannover, Germany

Received 9 November 2011; Accepted 8 December 2011

Academic Editor: T. B. Vree

Copyright © 2012 Reiner Buchhorn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Nissen, “ADHD drugs and cardiovascular risk,” New England Journal of Medicine, vol. 354, no. 14, pp. 1445–1448, 2006. View at Publisher · View at Google Scholar
  2. J. K. Triedman and M. E. Alexander, “Needle in a haystack: modeling the incidence of sudden cardiac arrest in healthy children,” Circulation, vol. 121, no. 11, pp. 1283–1285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Gould, B. T. Walsh, J. L. Munfakh et al., “Sudden death and use of stimulant medications in youths,” American Journal of Psychiatry, vol. 166, no. 9, pp. 992–1001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Elia and V. L. Vetter, “Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children?” Pediatric Drugs, vol. 12, no. 3, pp. 165–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Denchev, J. R. Kaltman, M. Schoenbaum, and B. Vitiello, “Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder,” Circulation, vol. 121, no. 11, pp. 1329–1337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Stiefel and F. M. C. Besag, “Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder,” Drug Safety, vol. 33, no. 10, pp. 821–842, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Samuels, K. Franco, F. Wan, and J. M. Sorof, “Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial,” Pediatric Nephrology, vol. 21, no. 1, pp. 92–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Prasad, A. J. Furr, S. Zhang, S. Ball, and A. J. Allen, “Baseline values from the electrocardiograms of children and adolescents with ADHD,” Child and Adolescent Psychiatry and Mental Health, vol. 1, article 11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. K. Leslie, M. E. Alexander, T. A. Trikalinos, J. T. Cohen, S. K. Parsons, and J. W. Newburger, “Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder,” Circulation. Cardiovascular quality and outcomes, vol. 1, no. 2, pp. 134–137, 2008. View at Google Scholar · View at Scopus
  10. M. Vaseghi and K. Shivkumar, “The role of the autonomic nervous system in sudden cardiac death,” Progress in Cardiovascular Diseases, vol. 50, no. 6, pp. 404–419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. T. La Rovere, J. T. Bigger Jr., F. I. Marcus, A. Mortara, and P. J. Schwartz, “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction,” Lancet, vol. 351, no. 9101, pp. 478–484, 1998. View at Publisher · View at Google Scholar
  12. L. Fei, M. H. Anderson, D. Katritsis et al., “Decreased heart rate variability in survivors of sudden cardiac death not associated with coronary artery disease,” British Heart Journal, vol. 71, no. 1, pp. 16–21, 1994. View at Google Scholar · View at Scopus
  13. M. Massin and G. Von Bernuth, “Normal ranges of heart rate variability during infancy and childhood,” Pediatric Cardiology, vol. 18, no. 4, pp. 297–302, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Umetani, D. H. Singer, R. McCraty, and M. Atkinson, “Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades,” Journal of the American College of Cardiology, vol. 31, no. 3, pp. 593–601, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Malik, “Heart rate variability: standards of measurement, physiological interpretation, and clinical use,” Circulation, vol. 93, no. 5, pp. 1043–1065, 1996. View at Google Scholar
  16. W. O. Cooper, L. A. Habel, C. M. Sox et al., “ADHD drugs and serious cardiovascular events in children and young adults,” New England Journal of Medicine, vol. 365, no. 20, pp. 1896–1904, 2011. View at Publisher · View at Google Scholar
  17. L. A. Habel, W. O. Cooper, C. M. Sox et al., “ADHD medications and risk of serious cardiovascular events in young and middle-aged adults,” Journal of the American Medical Association, vol. 306, no. 24, pp. 2673–2683, 2011. View at Google Scholar
  18. P. Shaw, “ADHD medications and cardiovascular risk—some heartening news,” Journal of the American Medical Association, vol. 306, no. 24, pp. 2723–2724.